NEWS | CONTACT | ESPAÑOL | CATALÀ Search Site Map About Us Presentation of the Company Company Background LACER in Figures Products Cardiovascular   Hypertension   Ischemic Heart Disease   Lipid Metabolism Disorders   Diabetes Peripheral Vascular Disorders Gastrointestinal Musculoskeletal Central Nervous System Oral Health   Anti-caries   Mechanical Dental Hygiene   Periodontal Disease   Halitosis   Children   Orthodontia   Sensitive Teeth   Whitener   Vitamins and Minerals   Xerostomia   Dental Prostheses Hair and Scalp Dermatology Body and Skin Care and Protection Allergy Analgesics Pruritus (itching) Services Cardiorisc R&D&i Pharmaceutical Division Lacer Personal Health Business Development Introduction Pharmaceutical Licensing   Introduction   Strategic Alliances   Alliance Management   In-licencing   Out-licensing   Contact Lacer Personal Health Efarmes (Generic Drugs)   Introduction   Contact Production for Other Companies International Markets   World Map   Introduction   Brazil   Colombia   Dominican Republic   El Salvador   Guatemala   Honduras   Israel   Japan   Mexico   Portugal   People's Republic of China   Turkey Industrial Division Introduction Activity Quality Capacity Production for other Companies Getting to Lacer Business Ethics LACER'S Code of Good Conduct Anefp Code of Good Conduct Farmaindustria's Code of Good Practices for the Promotion of Medicinal Products Work with us HR Policies Employment Opportunities Internship Opportunities Future Openings Your Health Allergies Caries General Moisturizing Haemorrhoids Hair Loss Halitosis How to Prevent a Heart Attack Hypersensitive Teeth Moisturizing the Hands Oral Care for Children Orthodontia Pain Periodontal Disease Protection from the Sun Skin Care after Exposure to the Sun Tired Legs Vitamins and Minerals Xerostomia (Dry Mouth) News Contact LACER PRO new product range Ekistol 100 mg tablets KEY FACTS   LACER acquires the product Talquistina. KEY LINKS All PDF documents require Adobe Reader ® © Copyright 2007  |  Site Map  |  Legal Notice